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Mol ( Figure S1 . Full sequence analyzed by primer extension analysis of the S. cerevisiae sarcin ricin loop and adjacent helices from ribosomal RNA treated with 0-200 µM cisplatin. Dideoxy sequencing ladder labeled by A, U, C, and G. Cisplatininduced stop sites are denoted by orange arrowheads and summarized in the secondary structure with orange lettering. Nucleotides which were not analyzed in this particular experiment are in black lettering in the secondary structure. Figure S2 . Primer extension analysis of the sarcin-ricin loop (SRL) region in ribosomal RNA extracted from S. cerevisiae treated with 0-300 µM cisplatin. This experiment used SRL primer B, a primer designed to probe further upstream than the one in Figure 3 . Dideoxy sequencing ladder labeled by A, U, C, and G. Cisplatin-induced stop sites are denoted by asterisks (*) and represent nucleotides 3' to a stable platinum adduct. Orange asterisk adjacent to the line plot analysis denotes the primary stop site in the terminal SRL region (A3029). Predicted platinum crosslinks between adjacent purines based on experimental results are colored orange and in bold on the S. cerevisiae secondary structure map. Figure S3 . Primer extension analysis of the S. cerevisiae peptidyl transferase center from ribosomal RNA treated with 0-300 µM cisplatin. Cisplatin-induced stop sites are denoted by orange arrowheads and summarized in the secondary strucutre with orange lettering. Endogenous ribosomal RNA modifications are specifically denoted. 2'-OCH 3 modifications are marked with circled M's or by (M) at the nucleotide position corresponding to the stop site 3' to the modification. Pseudouridine substitutions are labeled with "ψ". Regions of stable structure that nonspecifically inhibit primer extension in the absence of platinum are denoted on the sequencing gel by vertical purple lines. Nucleotides protected from Pt binding are marked on the sequencing gel by a vertical green line. Nucleotides which were not analyzed in this particular experiment in black lettering on the secondary structure.
